These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 30458613)
1. Attenuating Effects of Nortrachelogenin on IL-4 and IL-13 Induced Alternative Macrophage Activation and on Bleomycin-Induced Dermal Fibrosis. Pemmari A; Leppänen T; Paukkeri EL; Scotece M; Hämäläinen M; Moilanen E J Agric Food Chem; 2018 Dec; 66(51):13405-13413. PubMed ID: 30458613 [TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory Effects of Nortrachelogenin in Murine J774 Macrophages and in Carrageenan-Induced Paw Edema Model in the Mouse. Laavola M; Leppänen T; Eräsalo H; Hämäläinen M; Nieminen R; Moilanen E Planta Med; 2017 Apr; 83(6):519-526. PubMed ID: 27737478 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of interleukin-13 and its receptor in a murine model of bleomycin-induced scleroderma. Matsushita M; Yamamoto T; Nishioka K Int Arch Allergy Immunol; 2004 Dec; 135(4):348-56. PubMed ID: 15564778 [TBL] [Abstract][Full Text] [Related]
4. Pinosylvin Shifts Macrophage Polarization to Support Resolution of Inflammation. Kivimäki K; Leppänen T; Hämäläinen M; Vuolteenaho K; Moilanen E Molecules; 2021 May; 26(9):. PubMed ID: 34066748 [TBL] [Abstract][Full Text] [Related]
5. Myeloid-specific disruption of tyrosine phosphatase Shp2 promotes alternative activation of macrophages and predisposes mice to pulmonary fibrosis. Tao B; Jin W; Xu J; Liang Z; Yao J; Zhang Y; Wang K; Cheng H; Zhang X; Ke Y J Immunol; 2014 Sep; 193(6):2801-11. PubMed ID: 25127857 [TBL] [Abstract][Full Text] [Related]
6. TRPA1 as a potential factor and drug target in scleroderma: dermal fibrosis and alternative macrophage activation are attenuated in TRPA1-deficient mice in bleomycin-induced experimental model of scleroderma. Mäki-Opas I; Hämäläinen M; Moilanen E; Scotece M Arthritis Res Ther; 2023 Jan; 25(1):12. PubMed ID: 36698198 [TBL] [Abstract][Full Text] [Related]
7. Critical role of p38 MAPK in IL-4-induced alternative activation of peritoneal macrophages. Jiménez-Garcia L; Herránz S; Luque A; Hortelano S Eur J Immunol; 2015 Jan; 45(1):273-86. PubMed ID: 25328047 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of OSM and IL-6 impacts the polarization of pro-fibrotic macrophages and the development of bleomycin-induced lung fibrosis. Ayaub EA; Dubey A; Imani J; Botelho F; Kolb MRJ; Richards CD; Ask K Sci Rep; 2017 Oct; 7(1):13281. PubMed ID: 29038604 [TBL] [Abstract][Full Text] [Related]
9. IRAK-M promotes alternative macrophage activation and fibroproliferation in bleomycin-induced lung injury. Ballinger MN; Newstead MW; Zeng X; Bhan U; Mo XM; Kunkel SL; Moore BB; Flavell R; Christman JW; Standiford TJ J Immunol; 2015 Feb; 194(4):1894-904. PubMed ID: 25595781 [TBL] [Abstract][Full Text] [Related]
10. Novel Lignan and stilbenoid mixture shows anticarcinogenic efficacy in preclinical PC-3M-luc2 prostate cancer model. Yatkin E; Polari L; Laajala TD; Smeds A; Eckerman C; Holmbom B; Saarinen NM; Aittokallio T; Mäkelä SI PLoS One; 2014; 9(4):e93764. PubMed ID: 24699425 [TBL] [Abstract][Full Text] [Related]
12. AKT2 Regulates Pulmonary Inflammation and Fibrosis via Modulating Macrophage Activation. Nie Y; Sun L; Wu Y; Yang Y; Wang J; He H; Hu Y; Chang Y; Liang Q; Zhu J; Ye RD; Christman JW; Qian F J Immunol; 2017 Jun; 198(11):4470-4480. PubMed ID: 28455433 [TBL] [Abstract][Full Text] [Related]
14. Paired immunoglobulin-like receptor-B inhibits pulmonary fibrosis by suppressing profibrogenic properties of alveolar macrophages. Karo-Atar D; Moshkovits I; Eickelberg O; Königshoff M; Munitz A Am J Respir Cell Mol Biol; 2013 Apr; 48(4):456-64. PubMed ID: 23258232 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of Corilagin interference with IL-13/STAT6 signaling pathways in hepatic alternative activation macrophages in schistosomiasis-induced liver fibrosis in mouse model. Du P; Ma Q; Zhu ZD; Li G; Wang Y; Li QQ; Chen YF; Shang ZZ; Zhang J; Zhao L Eur J Pharmacol; 2016 Dec; 793():119-126. PubMed ID: 27845069 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of bleomycin-induced pulmonary fibrosis by nordihydroguaiaretic acid. The role of alveolar macrophage activation and mediator production. Phan SH; Kunkel SL Am J Pathol; 1986 Aug; 124(2):343-52. PubMed ID: 2426952 [TBL] [Abstract][Full Text] [Related]
17. Rac2 is required for alternative macrophage activation and bleomycin induced pulmonary fibrosis; a macrophage autonomous phenotype. Joshi S; Singh AR; Wong SS; Zulcic M; Jiang M; Pardo A; Selman M; Hagood JS; Durden DL PLoS One; 2017; 12(8):e0182851. PubMed ID: 28817691 [TBL] [Abstract][Full Text] [Related]
18. Paeoniflorin attenuates schistosomiasis japonica-associated liver fibrosis through inhibiting alternative activation of macrophages. Chu D; Du M; Hu X; Wu Q; Shen J Parasitology; 2011 Sep; 138(10):1259-71. PubMed ID: 21810309 [TBL] [Abstract][Full Text] [Related]
19. Tamibarotene Ameliorates Bleomycin-Induced Dermal Fibrosis by Modulating Phenotypes of Fibroblasts, Endothelial Cells, and Immune Cells. Toyama T; Asano Y; Akamata K; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Shudo K; Sato S; Kadono T J Invest Dermatol; 2016 Feb; 136(2):387-398. PubMed ID: 26967475 [TBL] [Abstract][Full Text] [Related]
20. Effects of IL-4 on pulmonary fibrosis and the accumulation and phenotype of macrophage subpopulations following thoracic irradiation. Groves AM; Johnston CJ; Misra RS; Williams JP; Finkelstein JN Int J Radiat Biol; 2016 Dec; 92(12):754-765. PubMed ID: 27539247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]